BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31462704)

  • 1. Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
    Liu X; Huang Q; Chen L; Zhang H; Schonbrunn E; Chen J
    Oncogene; 2020 Jan; 39(1):176-186. PubMed ID: 31462704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.
    Huang Q; Chen L; Schonbrunn E; Chen J
    EMBO J; 2020 Jul; 39(14):e104410. PubMed ID: 32511789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p53-MDMX interaction by casein kinase 1 alpha.
    Chen L; Li C; Pan Y; Chen J
    Mol Cell Biol; 2005 Aug; 25(15):6509-20. PubMed ID: 16024788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding.
    Wu S; Chen L; Becker A; Schonbrunn E; Chen J
    Mol Cell Biol; 2012 Dec; 32(23):4821-32. PubMed ID: 23028042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia.
    Xu W; Huang Z; Gan Y; Chen R; Huang Y; Xue B; Jiang S; Yu Z; Yu K; Zhang S
    Oncol Rep; 2020 Nov; 44(5):1895-1904. PubMed ID: 32901886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth.
    Huart AS; MacLaine NJ; Narayan V; Hupp TR
    PLoS One; 2012; 7(8):e43391. PubMed ID: 22916255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
    Sinnberg T; Menzel M; Kaesler S; Biedermann T; Sauer B; Nahnsen S; Schwarz M; Garbe C; Schittek B
    Cancer Res; 2010 Sep; 70(17):6999-7009. PubMed ID: 20699366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.
    Smith AE; Kulasekararaj AG; Jiang J; Mian S; Mohamedali A; Gaken J; Ireland R; Czepulkowski B; Best S; Mufti GJ
    Lancet Haematol; 2015 May; 2(5):e212-21. PubMed ID: 26688096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation.
    Chang CH; Kuo CJ; Ito T; Su YY; Jiang ST; Chiu MH; Lin YH; Nist A; Mernberger M; Stiewe T; Ito S; Wakamatsu K; Hsueh YA; Shieh SY; Snir-Alkalay I; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8035-E8044. PubMed ID: 28878021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
    Ueda K; Kumari R; Schwenger E; Wheat JC; Bohorquez O; Narayanagari SR; Taylor SJ; Carvajal LA; Pradhan K; Bartholdy B; Todorova TI; Goto H; Sun D; Chen J; Shan J; Song Y; Montagna C; Xiong S; Lozano G; Pellagatti A; Boultwood J; Verma A; Steidl U
    Cancer Cell; 2021 Apr; 39(4):529-547.e7. PubMed ID: 33667384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
    Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
    PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.
    Fuchs SNR; Stalmann USA; Snoeren IAM; Bindels E; Schmitz S; Banjanin B; Hoogenboezem RM; van Herk S; Saad M; Walter W; Haferlach T; Seillier L; Saez-Rodriguez J; Dugourd AJF; Lehmann KV; Ben-Neriah Y; Gleitz HFE; Schneider RK
    Blood Adv; 2024 Feb; 8(3):766-779. PubMed ID: 38147624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein kinase 1α regulates murine spermatogenesis via p53-Sox3 signaling.
    Lu C; Zhang D; Zhang J; Li L; Qiu J; Gou K; Cui S
    Development; 2022 Jul; 149(13):. PubMed ID: 35698877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways.
    Manni S; Carrino M; Manzoni M; Gianesin K; Nunes SC; Costacurta M; Tubi LQ; Macaccaro P; Taiana E; Cabrelle A; Barilà G; Martines A; Zambello R; Bonaldi L; Trentin L; Neri A; Semenzato G; Piazza F
    Oncotarget; 2017 Feb; 8(9):14604-14619. PubMed ID: 28099937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
    Schneider RK; Ademà V; Heckl D; Järås M; Mallo M; Lord AM; Chu LP; McConkey ME; Kramann R; Mullally A; Bejar R; Solé F; Ebert BL
    Cancer Cell; 2014 Oct; 26(4):509-20. PubMed ID: 25242043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
    Fuchs O
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):51-78. PubMed ID: 29788898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of myelodysplastic syndromes with deletion 5q.
    Lee JH; List A; Sallman DA
    Eur J Haematol; 2019 Mar; 102(3):203-209. PubMed ID: 30578738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations.
    Stengel A; Kern W; Haferlach T; Meggendorfer M; Haferlach C
    Genes Chromosomes Cancer; 2016 Oct; 55(10):777-85. PubMed ID: 27218649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.
    Heuser M; Meggendorfer M; Cruz MM; Fabisch J; Klesse S; Köhler L; Göhring G; Ganster C; Shirneshan K; Gutermuth A; Cerny-Reiterer S; Krönke J; Panagiota V; Haferlach C; Koenecke C; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Ehrlich S; Stamer K; Döhner K; Valent P; Schlegelberger B; Kroeger N; Ganser A; Haase D; Haferlach T; Thol F
    Leukemia; 2015 Sep; 29(9):1942-5. PubMed ID: 25792355
    [No Abstract]   [Full Text] [Related]  

  • 20. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.
    Rodriguez-Blanco J; Li B; Long J; Shen C; Yang F; Orton D; Collins S; Kasahara N; Ayad NG; McCrea HJ; Roussel MF; Weiss WA; Capobianco AJ; Robbins DJ
    Clin Cancer Res; 2019 Feb; 25(4):1379-1388. PubMed ID: 30487124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.